Opin vísindi

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure

Skoða venjulega færslu

dc.contributor Háskóli Íslands
dc.contributor University of Iceland
dc.contributor.author Robson, Joanna C
dc.contributor.author Dawson, Jill
dc.contributor.author Cronholm, Peter F
dc.contributor.author Milman, Nataliya
dc.contributor.author Kellom, Katherine
dc.contributor.author Ashdown, Susan
dc.contributor.author Easley, Ebony
dc.contributor.author Farrar, John T.
dc.contributor.author Gebhart, Don
dc.contributor.author Lanier, Georgia
dc.contributor.author McAlear, Carol A
dc.contributor.author Peck, Jacqueline
dc.contributor.author Luqmani, Raashid A
dc.contributor.author Shea, Judy A
dc.contributor.author Tómasson, Gunnar
dc.contributor.author Merkel, Peter A
dc.date.accessioned 2018-09-03T13:00:30Z
dc.date.available 2018-09-03T13:00:30Z
dc.date.issued 2018-01
dc.identifier.issn 1179-271X
dc.identifier.uri https://hdl.handle.net/20.500.11815/819
dc.description.abstract Objective: The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are multisystem diseases of the small blood vessels. Patients experience irreversible damage and psychological effects from AAV and its treatment. An international collaboration was created to investigate the impact of AAV on health-related quality of life (HRQoL), and develop a disease-specific patient-reported outcome measure to assess outcomes of importance to patients. Methods: Patients with AAV from the UK, USA, and Canada were interviewed to identify salient aspects of HRQoL affected by AAV. The study was overseen by a steering committee including four patient research partners. Purposive sampling of interviewees ensured representation of a range of disease manifestations and demographics. Inductive analysis was used to identify themes of importance to patients; these were further confirmed by a free-listing exercise in the US. Individual themes were recast into candidate items, which were scrutinized by patients, piloted through cognitive interviews and received a linguistic and translatability evaluation. Results: Fifty interviews, conducted to saturation, with patients from the UK, USA, and Canada, identified 55 individual themes of interest within seven broad domains: general health perceptions, impact on function, psychological perceptions, social perceptions, social contact, social role, and symptoms. Individual themes were constructed into >100 candidate questionnaire items, which were then reduced and refined to 35 candidate items. Conclusion: This is the largest international qualitative analysis of HRQoL in AAV to date, and the results have underpinned the development of 35 candidate items for a disease-specific, patient-reported outcome questionnaire.
dc.description.sponsorship Sponsored by the University of Oxford, the Vasculitis Clinical Research Consortium and the University of Ottawa. With support from the Medical Research Fund, Oxford, the Oxfordshire Health Services Research Committee (Ref 1098), the US National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR057319 and U01 AR51874), the National Center for Research Resources (U54 RR019497), and the Office of Rare Diseases Research. Oxford University Innovation funded the translatability exercise. Additional support received by a Patient-Centred Outcomes Research Institute Pilot Project Grant.
dc.format.extent 17-34
dc.language.iso en
dc.publisher Dove Medical Press Ltd.
dc.relation.ispartofseries Patient Related Outcome Measures;9
dc.rights info:eu-repo/semantics/openAccess
dc.subject ANCA-associated vasculitis
dc.subject Quality of life
dc.subject Patient-reported outcomes
dc.subject Granulomatosis
dc.subject Polyangiitis
dc.subject Blóðsjúkdómar
dc.subject Heilsufar
dc.subject Líðan
dc.subject Eigindlegar rannsóknir
dc.title Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
dc.type info:eu-repo/semantics/article
dcterms.license This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
dc.description.version Peer Reviewed
dc.identifier.journal Patient Related Outcome Measures
dc.identifier.doi 10.2147/PROM.S144992
dc.contributor.department Læknadeild (HÍ)
dc.contributor.department Faculty of Medicine (UI)
dc.contributor.school Heilbrigðisvísindasvið (HÍ)
dc.contributor.school School of Health Sciences (UI)


Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:

Skoða venjulega færslu